Request for Covid-19 Impact Assessment of this Report

Diagnostic and Biotech

Single-use Bioprocessing Market by Product (Bioreactors, Tangential-flow Filtration Devices, Depth Filters, Disposable Filter Cartridges, Media Bags & Containers, Mixing Systems, Tubing Assemblies, Sampling Systems, and Others), Application (Monoclonal Antibody Production, Vaccine Production, Plant Cell Cultivation, Patient Specific Cell Therapies, and Others), Method (Filtration, Storage, Cell Culture, Mixing, and Purification), and End User (Biopharmaceutical Manufacturers, Life Science R&D Companies & Academic Research Institutes, and Contract Research Organizations & Manufacturers) - Global Opportunity Analysis and Industry Forecast, 2017-2023

  • ALL1298410
  • 210 Pages
  • June 2017
  • Diagnostic and Biotech
Download Sample    Get Discount   
 

Single-use bioprocessing technology consists of disposable products that assist in manufacturing biopharmaceutical products. This technology has been rapidly adopted by various biopharmaceutical companies in the recent years. These technologies are applied in monoclonal antibody production, vaccine production, plant cell cultivation, patient specific cell therapies, and other applications. The key factors that drive the market growth include rise in adoption of single use technologies, low risk of product cross contamination, cost-effectiveness, and less floor space requirement. The global single-use bioprocessing market was valued at $2,800 million in 2016, and is expected to reach $9,342 million by 2023, registering a CAGR of 18.7% from 2017 to 2023.

The global single-use bioprocessing market is segmented on the basis of product, application, method, end user, and geography. Based on product, it is divided into bioreactors, tangential-flow filtration devices, depth filters, disposable filter cartridges, media bags & containers, mixing systems, tubing assemblies, sampling systems, and other products. Based on application, it is classified into monoclonal antibody production, vaccine production, plant cell cultivation, patient specific cell therapies, and others. Based on method, it is categorized into filtration, storage, cell culture, mixing, and purification. Based on end user, it is classified into biopharmaceutical manufacturers, life science R&D companies & academic research institutes, and contract research organizations & manufacturers. The media bags & assemblies segment generated the highest revenue in 2016, registering a CAGR of 18.1% from 2017 to 2023, and is anticipated to continue its dominance throughout the forecast period. In addition, single-use bioprocessing technologies are used in the production of monoclonal antibodies (mAb), and has generated the highest revenue in this application throughout the forecast period.

Geographically, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. In the recent years, Asia-Pacific has witnessed rapid growth in the single-use bioprocessing market This is attributed to the increasing adoption of single-use technologies by small biotechnology startups and biopharmaceutical companies in bioprocessing. In addition, several market players have focused on developing novel single use products for bio-manufacturing driving the market growth.

KEY BENEFITS FOR STAKEHOLDERS

  •  The study provides an in-depth analysis of the global single-use bioprocessing market along with the current trends and future estimations to elucidate the imminent investment pockets.
  •  Comprehensive analysis of the factors that drive and restrict the market growth is provided in the report.
  •  Comprehensive quantitative analysis of the industry is provided for the period of 2016‐2023 to assist stakeholders to capitalize on the prevailing market opportunities.
  •  Extensive analysis of the key segments of the industry helps in understanding the trends in products and technologies across the globe.
  •  Key market players and their strategies have been provided to understand the competitive outlook of the industry.

KEY MARKET SEGMENTS

 By Product

  •  Bioreactors
  •  Tangential-flow Filtration Devices
  •  Depth Filters
  •  Disposable Filter Cartridges
  •  Media Bags & Containers
  •  Mixing Systems
  •  Tubing Assemblies
  •  Sampling Systems
  •  Other Products

 By Method

  •  Filtration
  •  Storage
  •  Cell Culture
  •  Mixing
  •  Purification

 By Application

  •  Monoclonal Antibody Production
  •  Vaccine Production
  •  Plant Cell Cultivation
  •  Patient Specific Cell Therapies
  •  Other Applications

 By End User

  •  Biopharmaceutical Manufacturers
  •  Life Science R&D Companies & Academic Research Institutes
  •  Contract Research Organizations & Manufacturers

 By Region

  •  North America

    •  U.S.
    •  Canada
    •  Mexico

  •  Europe

    •  UK
    •  France
    •  Germany
    •  Italy
    •  Spain
    •  Rest of Europe

  •  Asia-Pacific

    •  Japan
    •  China
    •  India
    •  Australia
    •  Rest of Asia-Pacific

  •  LAMEA

    •  Brazil
    •  Turkey
    •  Argentina
    •  South Africa
    •  Rest of LAMEA

KEY MARKET PLAYERS

  •  Thermo Fisher Scientific
  •  Danaher Corporation
  •  GE Healthcare (General Electric Company)
  •  Sartorius Stedim Biotech S.A.
  •  Merck Millipore (Merck Group)
  •  3M Company
  •  Eppendorf AG
  •  Finesse Solutions, Inc.
  •  Applikon Biotechnology B.V.
  •  Cesco Bioengineering Co., Ltd.

The other players in the value chain include (profiles not included in the report)

  •  Octane Biotech Inc.
  •  PBS Biotech, Inc.
  •  Meissner Filtration Products, Inc.
  •  Sentinel Process Systems Inc.
  •  CMC Biologics (Asahi Glass Co.)
  •  Novasep
  •  PendoTECH
  •  BioPure Technology Ltd.

CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION

1.2. KEY BENEFITS

1.3. KEY MARKET SEGMENTS

1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research

1.4.2. Primary research

1.4.3. Analyst tools & models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE

3.2. KEY FINDINGS

3.2.1. Top investment pockets

3.2.2. Top winning strategies

3.3. PORTERS FIVE FORCES ANALYSIS

3.4. REGULATORY FRAMEWORK

3.5. MARKET SHARE ANALYSIS, 2016

3.6. MARKET DYNAMICS

3.6.1. Drivers

3.6.1.1. Increase in demand for single use technologies in biomanufacturing

3.6.1.2. Rise in adoption of SUT for continuous manufacturing

3.6.1.3. Lower risk of cross-contamination and reduced manufacturing cost

3.6.1.4. Increasing demand for flexible bioprocessing equipment and less floor space requirement

3.6.2. Restraints

3.6.2.1. Concerns regarding extractability and leachability issues

3.6.2.2. Stringent regulations regarding use of disposable bioprocessing systems

3.6.3. Opportunities

3.6.3.1. Untapped developing regions

CHAPTER 4 SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. BIOREACTORS

4.2.1. Key market trends

4.2.2. Growth factors and opportunities

4.2.3. Market size and forecast

4.3. TANGENTIAL-FLOW FILTRATION DEVICES

4.3.1. Key market trends

4.3.2. Growth factors and opportunities

4.3.3. Market size and forecast

4.4. DEPTH FILTERS

4.4.1. Key market trends

4.4.2. Growth factors and opportunities

4.4.3. Market size and forecast

4.5. DISPOSABLE FILTER CARTRIDGES

4.5.1. Key market trends

4.5.2. Growth factors and opportunities

4.5.3. Market size and forecast

4.6. MEDIA BAGS & CONTAINERS

4.6.1. Key market trends

4.6.2. Growth factors and opportunities

4.6.3. Market size and forecast

4.7. MIXING SYSTEMS

4.7.1. Key market trends

4.7.2. Growth factors and opportunities

4.7.3. Market size and forecast

4.8. TUBING ASSEMBLIES

4.8.1. Key market trends

4.8.2. Growth factors and opportunities

4.8.3. Market size and forecast

4.9. SAMPLING SYSTEMS

4.9.1. Key market trends

4.9.2. Growth factors and opportunities

4.9.3. Market size and forecast

4.10. OTHER PRODUCTS

4.10.1. Key market trends

4.10.2. Growth factors and opportunities

4.10.3. Market size and forecast

CHAPTER 5 SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. MONOCLONAL ANTIBODY PRODUCTION

5.2.1. Market size and forecast

5.3. VACCINE PRODUCTION

5.3.1. Market size and forecast

5.4. PLANT CELL CULTIVATION

5.4.1. Market size and forecast

5.5. PATIENT SPECIFIC CELL THERAPIES

5.5.1. Market size and forecast

5.6. OTHER APPLICATIONS

5.6.1. Market size and forecast

CHAPTER 6 SINGLE-USE BIOPROCESSING MARKET, BY METHOD

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. FILTRATION

6.2.1. Market size and forecast

6.3. STORAGE

6.3.1. Market size and forecast

6.4. CELL CULTURE

6.4.1. Market size and forecast

6.5. MIXING

6.5.1. Market size and forecast

6.6. PURIFICATION

6.6.1. Market size and forecast

CHAPTER 7 SINGLE-USE BIOPROCESSING MARKET, BY END USERS

7.1. OVERVIEW

7.1.1. Market size and forecast

7.2. BIOPHARMACEUTICAL MANUFACTURERS

7.2.1. Market size and forecast

7.3. LIFE SCIENCE R&D COMPANIES & ACADEMIC RESEARCH INSTITUTES

7.3.1. Market size and forecast

7.4. CONTRACT RESEARCH ORGANIZATIONS & MANUFACTURERS

7.4.1. Market size and forecast

CHAPTER 8 SINGLE-USE BIOPROCESSING MARKET, BY GEOGRAPHY

8.1. OVERVIEW

8.1.1. Market size and forecast

8.2. NORTH AMERICA

8.2.1. Key market trends

8.2.2. Key growth factors and opportunities

8.2.3. Market size and forecast

8.2.3.1. U.S. market size and forecast

8.2.3.2. Mexico market size and forecast

8.2.3.3. Canada market size and forecast

8.3. EUROPE

8.3.1. Key market trends

8.3.2. Key growth factors and opportunities

8.3.3. Market size and forecast

8.3.3.1. UK market size and forecast

8.3.3.2. France market size and forecast

8.3.3.3. Germany market size and forecast

8.3.3.4. Italy market size and forecast

8.3.3.5. Spain market size and forecast

8.3.3.6. Rest of Europe market size and forecast

8.4. ASIA-PACIFIC

8.4.1. Key market trends

8.4.2. Key growth factors and opportunities

8.4.3. Market size and forecast

8.4.3.1. Japan market size and forecast

8.4.3.2. China market size and forecast

8.4.3.3. India market size and forecast

8.4.3.4. Australia market size and forecast

8.4.3.5. Rest of Asia-Pacific market size and forecast

8.5. LAMEA

8.5.1. Key market trends

8.5.2. Key growth factors and opportunities

8.5.3. Market size and forecast

8.5.3.1. Brazil market size and forecast

8.5.3.2. Turkey market size and forecast

8.5.3.3. Argentina market size and forecast

8.5.3.4. South Africa market size and forecast

8.5.3.5. Rest of LAMEA market size and forecast

CHAPTER 9 COMPANY PROFILES

9.1. THERMO FISHER SCIENCTIFIC

9.1.1. Company overview

9.1.2. Company snapshot

9.1.3. Operating business segments

9.1.4. Business performance

9.1.5. Key strategic moves and developments

9.2. DANAHER CORPORATION

9.2.1. Company overview

9.2.2. Company snapshot

9.2.3. Operating business segments

9.2.4. Business performance

9.2.5. Key strategic moves and developments

9.3. GE HEALTHCARE

9.3.1. Company overview

9.3.2. Company snapshot

9.3.3. Operating business segments

9.3.4. Business performance

9.3.5. Key strategic moves and developments

9.4. SARTORIUS STEDIM BIOTECH S.A

9.4.1. Company overview

9.4.2. Company snapshot

9.4.3. Operating business segments

9.4.4. Business performance

9.4.5. Key strategic moves and developments

9.5. MERCK MILIPORE

9.5.1. Company overview

9.5.2. Company snapshot

9.5.3. Operating business segments

9.5.4. Business performance

9.5.5. Key strategic moves and developments

9.6. 3M COMPANY

9.6.1. Company overview

9.6.2. Company snapshot

9.6.3. Operating business segments

9.6.4. Business performance

9.6.5. Key strategic moves and developments

9.7. EPPENDORF AG

9.7.1. Company overview

9.7.2. Company snapshot

9.7.3. Operating business segments

9.7.4. Business performance

9.7.5. Key strategic moves and developments

9.8. FINESSE SOLUTIONS, INC.

9.8.1. Company overview

9.8.2. Company snapshot

9.8.3. Operating business segments

9.8.4. Business performance

9.8.5. Key strategic moves and developments

9.9. APPLIKON BIOTECHNOLOGY

9.9.1. Company overview

9.9.2. Company snapshot

9.9.3. Operating business segments

9.9.4. Business performance

9.9.5. Key strategic moves and developments

9.10. CESCO BIOENGINEERING C0. LTD.

9.10.1. Company overview

9.10.2. Company snapshot

9.10.3. Operating business segments

9.10.4. Business performance

9.10.5. Key strategic moves and developments

LIST OF TABLES

TABLE 1. GLOBAL SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2016-2023 ($MILLION)

TABLE 2. GLOBAL SINGLE USE BIOPROCESSING (SUB) MARKET FOR BIOREACTORS, BY REGION, 2016-2023 ($MILLION)

TABLE 3. GLOBAL SUB MARKET FOR TANGENTIAL-FLOW FILTRATION DEVICES, BY REGION, 2016-2023 ($MILLION)

TABLE 4. GLOBAL SUB MARKET FOR DEPTH FILTERS, BY REGION, 2016-2023 ($MILLION)

TABLE 5. GLOBAL SUB MARKET FOR DISPOSABLE FILTER CARTRIDGES, BY REGION, 2016-2023 ($MILLION)

TABLE 6. GLOBAL SUB MARKET FOR MEDIA BAGS & CONTAINERS, BY REGION, 2016-2023 ($MILLION)

TABLE 7. GLOBAL SUB MARKET FOR MIXING SYSTEMS, BY REGION, 2016-2023 ($MILLION)

TABLE 8. GLOBAL SUB MARKET FOR TUBING ASSEMBLIES, BY REGION, 2016-2023 ($MILLION)

TABLE 9. GLOBAL SUB MARKET FOR SAMPLING SYSTEMS, BY REGION, 2016-2023 ($MILLION)

TABLE 10. GLOBAL SUB MARKET FOR OTHER PRODUCTS, BY REGION, 2016-2023 ($MILLION)

TABLE 11. GLOBAL SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION, 2016-2023 ($MILLION)

TABLE 12. GLOBAL SUB MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY REGION, 2016-2023 ($MILLION)

TABLE 13. GLOBAL SUB MARKET FOR VACCINE PRODUCTION, BY REGION, 2016-2023 ($MILLION)

TABLE 14. GLOBAL SUB MARKET FOR PLANT CELL CULTIVATION, BY REGION, 2016-2023 ($MILLION)

TABLE 15. GLOBAL SUB MARKET FOR PATIENT SPECIFIC CELL THERAPIES, BY REGION, 2016-2023 ($MILLION)

TABLE 16. GLOBAL SUB MARKET FOR OTHER APPLICATIONS, BY REGION, 2016-2023 ($MILLION)

TABLE 17. GLOBAL SINGLE-USE BIOPROCESSING MARKET, BY METHOD, 2016-2023 ($MILLION)

TABLE 18. GLOBAL SUB MARKET FOR FILTRATION METHOD, BY REGION, 2016-2023 ($MILLION)

TABLE 19. GLOBAL SUB MARKET FOR STORAGE METHOD, BY REGION, 2016-2023 ($MILLION)

TABLE 20. GLOBAL SUB MARKET FOR CELL CULTURE METHOD, BY REGION, 2016-2023 ($MILLION)

TABLE 21. GLOBAL SUB MARKET FOR MIXING METHOD, BY REGION, 2016-2023 ($MILLION)

TABLE 22. GLOBAL SUB MARKET FOR PURIFICATION METHOD, BY REGION, 2016-2023 ($MILLION)

TABLE 23. GLOBAL SINGLE-USE BIOPROCESSING MARKET, BY END USERS, 2016-2023 ($MILLION)

TABLE 24. GLOBAL SUB MARKET FOR BIOPHARMACEUTICAL MANUFACTURERS, BY REGION, 2016-2023 ($MILLION)

TABLE 25. GLOBAL SUB MARKET FOR LIFE SCIENCE R&D COMPANIES, BY REGION, 2016-2023 ($MILLION)

TABLE 26. GLOBAL SUB MARKET FOR CONTRACT RESEARCH ORGANIZATIONS & MANUFACTURERS, BY REGION, 2016-2023 ($MILLION)

TABLE 27. GLOBAL SINGLE-USE BIOROCESSING MARKET, BY REGION, 2016-2023 ($MILLION)

TABLE 28. NORTH AMERICA SINGLE-USE BIOROCESSING MARKET, BY COUNTRY, 2016-2023 ($MILLION)

TABLE 29. NORTH AMERICA SINGLE-USE BIOROCESSING MARKET, BY PRODUCT, 2016-2023 ($MILLION)

TABLE 30. NORTH AMERICA SINGLE-USE BIOROCESSING MARKET, BY APPLICATION, 2016-2023 ($MILLION)

TABLE 31. NORTH AMERICA SINGLE-USE BIOROCESSING MARKET, BY METHOD, 2016-2023 ($MILLION)

TABLE 32. NORTH AMERICA SINGLE-USE BIOROCESSING MARKET, BY END USER, 2016-2023 ($MILLION)

TABLE 33. EUROPE SINGLE-USE BIOPROCESSING MARKET, BY COUNTRY, 2016-2023 ($MILLION)

TABLE 34. EUROPE SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2016-2023 ($MILLION)

TABLE 35. EUROPE SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION, 2016-2023 ($MILLION)

TABLE 36. EUROPE SINGLE-USE BIOROCESSING MARKET, BY METHOD, 2016-2023 ($MILLION)

TABLE 37. EUROPE SINGLE-USE BIOROCESSING MARKET, BY END USER, 2016-2023 ($MILLION)

TABLE 38. ASIA-PACIFIC SINGLE-USE BIOPROCESSING MARKET, BY COUNTRY, 2016-2023 ($MILLION)

TABLE 39. ASIA-PACIFIC SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2016-2023 ($MILLION)

TABLE 40. ASIA-PACIFIC SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION, 2016-2023 ($MILLION)

TABLE 41. ASIA-PACIFIC SINGLE-USE BIOPROCESSING MARKET, BY METHOD, 2016-2023 ($MILLION)

TABLE 42. ASIA-PACIFIC SINGLE-USE BIOPROCESSING MARKET, BY END USER, 2016-2023 ($MILLION)

TABLE 43. LAMEA SINGLE-USE BIOPROCESSING MARKET, BY COUNTRY, 2016-2023 ($MILLION)

TABLE 44. LAMEA SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2016-2023 ($MILLION)

TABLE 45. LAMEA SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION, 2016-2023 ($MILLION)

TABLE 46. LAMEA SINGLE-USE BIOROCESSING MARKET, BY METHOD, 2016-2023 ($MILLION)

TABLE 47. LAMEA SINGLE-USE BIOROCESSING MARKET, BY END USER, 2016-2023 ($MILLION)

TABLE 48. THERMO FISHER: COMPANY SNAPSHOT

TABLE 49. THERMO FISHER: OPERATING SEGMENTS

TABLE 50. DANAHER: COMPANY SNAPSHOT

TABLE 51. DANAHER: OPERATING SEGMENTS

TABLE 52. GE: COMPANY SNAPSHOT

TABLE 53. GE: OPERATING SEGMENTS

TABLE 54. SARTORIUS: COMPANY SNAPSHOT

TABLE 55. SARTORIUS: OPERATING SEGMENTS

TABLE 56. MERCK: COMPANY SNAPSHOT

TABLE 57. MERCK: OPERATING SEGMENTS

TABLE 58. 3M: COMPANY SNAPSHOT

TABLE 59. 3M: OPERATING SEGMENTS

TABLE 60. EPPENDORF: COMPANY SNAPSHOT

TABLE 61. EPPENDORF: OPERATING SEGMENTS

TABLE 62. FINESSE: COMPANY SNAPSHOT

TABLE 63. FINESSE: OPERATING SEGMENTS

TABLE 64. APPLIKON: COMPANY SNAPSHOT

TABLE 65. APPLIKON: OPERATING SEGMENTS

TABLE 66. CESCO: COMPANY SNAPSHOT

TABLE 67. CESCO: OPERATING SEGMENTS

LIST OF FIGURES

FIGURE 1. GLOBAL SINGLE-USE BIOPROCESSING MARKET, 2016-2023

FIGURE 2. SEGMENTATION OF GLOBAL SINGLE-USE BIOPROCESSING MARKET

FIGURE 3. TOP INVESTMENT POCKETS IN GLOBAL SINGLE-USE BIOPROCESSING MARKET

FIGURE 4. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION (2014-2017)

FIGURE 5. TOP WINNING STRATEGIES: NATURE AND TYPE

FIGURE 6. TOP WINNING STRATEGIES: NATURE AND COMPANY

FIGURE 7. BARGAINING POWER OF BUYERS

FIGURE 8. BARGAINING POWER OF SUPPLIERS

FIGURE 9. THREAT OF NEW ENTRANTS

FIGURE 10. THREAT OF SUBSTITUTION

FIGURE 11. COMPETITIVE RIVALRY

FIGURE 12. RESTRAINTS AND DRIVERS: GLOBAL SINGLE-USE BIOPROCESSING MARKET

FIGURE 13. U.S. SINGLE-USE BIOPROCESSING MARKET, 2016-2023 ($MILLION)

FIGURE 14. MEXICO SINGLE-USE BIOPROCESSING MARKET, 2016-2023 ($MILLION)

FIGURE 15. CANADA SINGLE-USE BIOPROCESSING MARKET, 2016-2023 ($MILLION)

FIGURE 16. UK SINGLE-USE BIOPROCESSING MARKET, 2016-2023 ($MILLION)

FIGURE 17. FRANCE SINGLE-USE BIOPROCESSING MARKET, 2016-2023 ($MILLION)

FIGURE 18. GERMANY SINGLE-USE BIOPROCESSING MARKET, 2016-2023 ($MILLION)

FIGURE 19. ITALY SINGLE-USE BIOPROCESSING MARKET, 2016-2023 ($MILLION)

FIGURE 20. SPAIN SINGLE-USE BIOPROCESSING MARKET, 2016-2023 ($MILLION)

FIGURE 21. REST OF EUROPE SINGLE-USE BIOPROCESSING MARKET, 2016-2023 ($MILLION)

FIGURE 22. JAPAN SINGLE-USE BIOPROCESSING MARKET, 2016-2023 ($MILLION)

FIGURE 23. CHINA SINGLE-USE BIOPROCESSING MARKET, 2016-2023 ($MILLION)

FIGURE 24. INDIA SINGLE-USE BIOPROCESSING MARKET, 2016-2023 ($MILLION)

FIGURE 25. AUSTRALIA SINGLE-USE BIOPROCESSING MARKET, 2016-2023 ($MILLION)

FIGURE 26. REST OF ASIA-PACIFIC SINGLE-USE BIOPROCESSING MARKET, 2016-2023 ($MILLION)

FIGURE 27. BRAZIL SINGLE-USE BIOPROCESSING MARKET, 2016-2023 ($MILLION)

FIGURE 28. TURKEY SINGLE-USE BIOPROCESSING MARKET, 2016-2023 ($MILLION)

FIGURE 29. ARGENTINA SINGLE-USE BIOPROCESSING MARKET, 2016-2023 ($MILLION)

FIGURE 30. SOUTH AFRICA SINGLE-USE BIOPROCESSING MARKET, 2016-2023 ($MILLION)

FIGURE 31. REST OF LAMEA SINGLE-USE BIOPROCESSING MARKET, 2016-2023 ($MILLION)

FIGURE 32. THERMO FISHER: NET SALES, 2014-2016 ($MILLION)

FIGURE 33. THERMO FISHER: REVENUE BY SEGMENT, 2016 (%)

FIGURE 34. THERMO FISHER: REVENUE BY GEOGRAPHY, 2016 (%)

FIGURE 35. DANAHER: NET SALES, 2014-2016 ($MILLION)

FIGURE 36. DANAHER: REVENUE BY SEGMENT, 2016 (%)

FIGURE 37. DANAHER: REVENUE BY GEOGRAPHY, 2016 (%)

FIGURE 38. GE: NET SALES, 2014-2016 ($MILLION)

FIGURE 39. GE: REVENUE BY SEGMENT, 2016 (%)

FIGURE 40. GE: REVENUE BY GEOGRAPHY, 2016 (%)

FIGURE 41. SARTORIUS: NET SALES, 2014-2016 ($MILLION)

FIGURE 42. SARTORIUS: REVENUE BY SEGMENT, 2016 (%)

FIGURE 43. SARTORIUS: REVENUE BY GEOGRAPHY, 2016 (%)

FIGURE 44. MERCK: NET SALES, 2014-2016 ($MILLION)

FIGURE 45. MERCK: REVENUE BY SEGMENT, 2016 (%)

FIGURE 46. MERCK: REVENUE BY GEOGRAPHY, 2016 (%)

FIGURE 47. 3M: NET SALES, 2014-2016 ($MILLION)

FIGURE 48. 3M: REVENUE BY SEGMENT, 2016 (%)

FIGURE 49. 3M: REVENUE BY GEOGRAPHY, 2016 (%)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

2017-2021 UK Hemostasis Diagnostics Market: Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers

Complete report $6,100.  DataPack (test volumes, sales forecasts, supplier shares) $3,950.

Summary

This comprehensive report contains 409 pages, 35 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the UK coagulation testing market duri...

  • Publish Date: February 7, 2017
  • $750
2017-2021 US Hemostasis Diagnostics Market: Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers

Complete report $9,600.  DataPack (test volumes, sales forecasts, supplier shares) $6,200.

Summary

This comprehensive report contains 424 pages, 37 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the US coagulation testing market during the...

  • Publish Date: February 7, 2017
  • $750
2017-2021 Immunohematology and Infectious Disease Screening Market: Competitive Analysis of Major Suppliers and Emerging Market Entrants

This new report from VPGMarketResearch.com provides strategic assessments of major blood banking product suppliers and emerging market entrants. The report presents analyses of major current and emerging suppliers in terms of their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.

Con...

  • Publish Date: February 7, 2017
  • $750